SEC Form 3 · accession 0001209191-15-039626
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kelly Blackburn
Officer — See Remarks
Period of report
May 6, 2015
Accepted (ET)
May 6, 2015 · 8:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 279 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.06 | holding | — | — | — | — | Jul 11, 2023 | Common Stock | 55,191 | — | D |
| Stock Option (right to buy)F2 | $4.06 | holding | — | — | — | — | Mar 5, 2024 | Common Stock | 4,749 | — | D |
| Stock Option (right to buy)F3 | $9.15 | holding | — | — | — | — | Apr 17, 2025 | Common Stock | 25,144 | — | D |
Explanation of responses
- F11/6th of the shares subject to this option shall vest and become exercisable on July 8, 2014 and the remaining shares subject to this option shall vest and become exercisable in 60 equal monthly installments beginning on July 8, 2014. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- F2The shares subject to this option shall vest and become exercisable in 72 equal monthly installments beginning on January 1, 2014. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- F3The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on April 17, 2015. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Remarks
Vice President, Clinical Affairs Exhibit List Exhibit 24.1 - Power of Attorney